NEW YORK — The first chimeric antigen receptor (CAR) T-cell product to target autoimmune diseases is showing promise for those with severe dermatologic manifestations, based on studies showing ...
When the COVID-19 pandemic shut down international travel in 2020, Michigan State University researcher Eric Benbow faced a ...
City researchers win patent for farm solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results